•
Sep 30, 2018

Leap Therapeutics Q3 2018 Earnings Report

EPS
-$5.5
Previous year: -$7.3
-24.7%
Cash and Equivalents
$23.2M
Previous year: $14.2M
+63.7%
Total Assets
$27.1M
Previous year: $17.6M
+54.3%

Leap Therapeutics

Leap Therapeutics